|

Bevacizumab (Avastin) Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1/2: 2

Top Sponsors

  • Sun Yat-sen University1
  • Anbogen Therapeutics, Inc.1

Indications

  • Colorectal Cancer Metastatic2
  • Cancer2
  • Colorectal Cancer (Diagnosis)1
  • Immunotherapy1
  • Colorectal Cancer (CRC)1

Other2 trials

A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC
Phase 1/2
ctDNA-Guided Cetuximab or Bevacizumab Plus Trifluridine/Tipiracil in RAS/BRAF Wild-Type mCRC
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.